MEDLINE Abstract: Introduction<BR>: Successful population-level antiretroviral therapy (ART) adherence will be necessary to realize both the clinical and prevention benefits of antiretroviral scale-up and, ultimately, the end of AIDS. Although …
AimTo determine the prevalence and factors associated with hepatitis B virus infection among pregnant women attending antenatal clinic in Mulago Hospital.DesignCross-sectional observational study.SettingMulago National Referral Hospital, Uganda, antenatal clinic.ParticipantsWe randomly …
Objective We monitored a large-scale implementation of the Simple Amplification-Based Assay semi-quantitative viral load test for HIV-1 version I (SAMBA I Viral Load = SAMBA I VL) within Medecins Sans …
Objective: We sought to estimate the incidence and predictors of all-cause mortality 6 months after heart failure hospitalization in Uganda.Methods: Mbarara Heart Failure Registry is a cohort of patients hospitalized …
Purpose: To characterize bone marrow aspirateâderived fibrin clot (BMA clot) and evaluate the clinical result of meniscal repair with a BMA clot for isolated meniscal injury in the avascular zone. …
Data on the course of major depressive disorder (MDD) among people living with HIV (PLWH) are needed to inform refinement of screening and interventions for MDD. This paper describes the …
Nine papers explore the history of global health initiatives to control disease in Africa. Papers discuss the long history of smallpox eradication--lessons for global health in Africa (William H. Schneider); …
The Sugar Corporation of Uganda Limited (SCOUL) factory in Lugazi is dotted with a lush terraced sugarcane vegetation and meandering streams of fresh water providing breathtaking beauty. For 90 years, …
Background Universal antiretroviral therapy (ART) with annual population testing and a multidisease, patient-centered strategy could reduce new human immunodeficiency virus (HIV) infections and improve community health. Methods We randomly assigned …
BACKGROUND AND AIMS: Major adverse cardiac events (MACE) remain a leading cause of mortality in chronic kidney disease (CKD). Apabetalone is an orally available inhibitor of bromodomain & extraterminal (BET) …